Evidence map›Paper›PMID 36582251›Full record

ArticleFrontiers in immunology2022

Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands.

Fay Probert, Tianrong Yeo, Yifan Zhou, Megan Sealey, Siddharth Arora, Jacqueline Palace, Timothy D W Claridge, Rainer Hillenbrand, Johanna Oechtering, Jens Kuhle and 2 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 0 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Fay ProbertDepartment of Chemistry, University of Oxford, Oxford, United Kingdom.
Tianrong YeoDepartment of Pharmacology, University of Oxford, Oxford, United Kingdom.
Yifan ZhouDepartment of Pharmacology, University of Oxford, Oxford, United Kingdom.
Megan SealeyDepartment of Pharmacology, University of Oxford, Oxford, United Kingdom.
Siddharth AroraDepartment of Mathematics, University of Oxford, Oxford, United Kingdom.
Jacqueline PalaceNuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Timothy D W ClaridgeDepartment of Chemistry, University of Oxford, Oxford, United Kingdom.
Rainer HillenbrandBiomarker Development, Novartis Pharma AG, Basel, Switzerland.
Johanna OechteringNeurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Jens KuhleNeurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
David LeppertNeurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Daniel C AnthonyDepartment of Pharmacology, University of Oxford, Oxford, United Kingdom.
University of Oxford · GBUniversity of Basel · CHDuke-NUS Medical School · SGNational Institutes of Health · USNovartis (Switzerland) · CHUniversity Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2021.811351.].

Indexed as

biomarkerdiagnosismetabolomics (OMICS)multiple sclerosis (MS)oligoclonal bandproteomics

Identifiers

PMID36582251
PMCPMC9793797
OpenAlexW4311346054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.